메뉴 건너뛰기




Volumn 140, Issue 6 SUPPL., 2000, Pages

Abciximab: Cost-effective survival advantage in clinical trials and clinical practice

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; TIROFIBAN;

EID: 0033674327     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.111613     Document Type: Article
Times cited : (6)

References (25)
  • 2
    • 0002203791 scopus 로고    scopus 로고
    • Economics of glycoprotein IIb/IIIa inhibition
    • Lincoff AM, Topol EJ, editors. Contemporary cardiology: platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease. Totowa (NJ): Humana Press Inc
    • (1999) , pp. 253-266
    • Mark, D.B.1
  • 3
    • 0002321256 scopus 로고    scopus 로고
    • Medical economics in cardiovascular medicine
    • Topol EJ, editor. Textbook of cardiovascular medicine. New York: Lippincott-Raven
    • (1997) , pp. 1033-1062
    • Mark, D.B.1
  • 4
    • 0033566637 scopus 로고    scopus 로고
    • Time course, magnitude and consistency of platelet inhibition of abciximab, tirofiban or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention
    • (1999) Am J Cardiol , vol.84 , pp. 391-395
    • Kereiakes, D.J.1    Broderick, T.M.2    Roth, E.M.3
  • 5
    • 2242477091 scopus 로고
    • Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty
    • (1994) N Engl J Med , vol.330 , pp. 956-961
  • 6
    • 1842369101 scopus 로고
    • Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
    • (1994) N Engl J Med , vol.336 , pp. 1689-1696
  • 8
    • 0032508297 scopus 로고    scopus 로고
    • Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with the use of platelet glycoprotein IIb/IIIa blockade
    • (1998) Lancet , vol.352 , pp. 87-92
  • 9
    • 0033547597 scopus 로고    scopus 로고
    • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicenter randomized trial
    • (1999) Lancet , vol.354 , pp. 2019-2024
    • Topol, E.J.1    Mark, D.B.2    Lincoff, A.M.3
  • 10
    • 0000656559 scopus 로고    scopus 로고
    • Effects of competitive platelet glycoprotein IIb/IIIa inhibition with integrilin in reducing complications of percutaneous coronary intervention
    • (1997) Lancet , vol.349 , pp. 1422-1428
  • 11
    • 0343376106 scopus 로고    scopus 로고
    • Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis
    • (1997) Circulation , vol.96 , pp. 1445-1453
  • 13
    • 0030918995 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
    • (1997) Lancet , vol.349 , pp. 1429-1435
  • 14
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes without persistent ST-segment elevation
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 17
    • 3543135271 scopus 로고    scopus 로고
    • Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino R.B., Jr.1
  • 20
    • 0002013325 scopus 로고    scopus 로고
    • Time preference
    • Gold MR, Siegel JE, Russell LB, et al, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press
    • (1996) , pp. 214-246
    • Lipscomb, J.1    Weinstein, M.C.2    Torrence, G.W.3
  • 21
  • 22
    • 9544243719 scopus 로고    scopus 로고
    • Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high risk coronary angioplasty
    • (1996) Circulation , vol.94 , pp. 629-635
    • Mark, D.B.1    Talley, J.D.2    Topol, E.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.